We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
This report by the Advisory Council on the Misuse of Drugs investigates the increase of drug-related deaths in the UK.
This report has considered the harms and control of 2-methyl-AP-237 and other closely related acyl piperazine opioids.
The Advisory Council on the Misuse of Drugs has undertaken a review of the availability and implementation of naloxone in the UK.
The Advisory Council on the Misuse of Drugs call for evidence, collecting written evidence to better understand internet-facilitated drug markets (IFDMs).
First published during the 2022 to 2024 Sunak Conservative government
The Advisory Council on the Misuse of Drugs (ACMD) seeks to gather insight into current government-led drug prevention policies and landscape across the UK.
Report from the ACMD providing advice to the government on the changing age profile of people accessing drug treatment and the challenges faced by this cohort in the UK.
This report provides an updated harms assessment to the ACMD's previous reports on synthetic cannabinoid receptor agonists.
This report examines the evidence of prevalence and harms in the UK of several novel benzodiazepines and provides advice to the government.
Call for evidence from the Advisory Council on the Misuse of Drugs on the prevalence and drivers of powder cocaine use by young people and adults.
The Advisory Council on the Misuse of Drugs makes recommendations to government on the control of dangerous or otherwise harmful drugs, including classification and scheduling under the Misuse of Drugs Act 1971 and its regul…
Chair of the Advisory Council on the Misuse of Drugs writes to Karen Bradley MP about Estra-4,9-diene-3,17-dione, also known as Dienedione.
The Advisory Council on the Misuse of Drugs (ACMD) has today (6 March 2023) published an updated harms assessment of nitrous oxide.
Home Secretary to receive advice on cannabis-related medicinal products.
First published during the 2016 to 2019 May Conservative government
ACMD report providing advice to the government on the factors that make the homeless population vulnerable to substance misuse harms and how these can reduced.
In March 2012 the ACMD advised that methoxetamine be subject to a temporary class drug order.
The ACMD have considered the harms associated with the use of O-desmethyltramadol and recommend that O-desmethyltramadol is controlled.
Report by the Advisory Council on the Misuse of Drugs (ACMD) reviewing the use of cocaine powder and its impact on British society.
Report to the Minister for Crime Prevention, which recommends a revised generic description of ‘third generation’ synthetic cannabinoids.
This report advises government on the number and nature of known fentanyl analogues, risk factors, pharmacology, toxic effects and misuse and associated harms.
This report provides an updated assessment of the health and social harms of nitrous oxide.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).